Preferential localization human adherent lymphokine-activated killer cells tumor microcirculation efficacy adoptive immunotherapy solid tumors lymphokine-activated effector cells ability cells tumor tissues first quantitative study vivo movement adherent lymphokine-activated killer A-LAK cells cells low-dose normal mature granulation tissue implant carcinoma grown rabbit ear chamber small proportion A-LAK cells tumor microcirculation vivo increased frequency long-term adhesive interactions tumor vasculature Stasis blood flow tumor vasculature days injection Subsequent necrosis tumors diffuse infiltrates lymphocytes monocytes granulocytes interstitial space tumor Development necrosis low ratios effector cells cells addition direct cytotoxicity response adoptive immunotherapy tumor vasculature novel mechanism adoptive immunotherapy account development improved strategies cancer treatment 